Healthcare operators and medical facility developers sit in a capital market that is simultaneously deep and poorly organized. There is no shortage of institutional interest in healthcare real estate, clinical platform roll-ups, and medical equipment finance — but the instruments available to a single-site clinic operator, an ambulatory surgical center group, or a specialty healthcare developer are fragmented across real estate lenders, healthcare-focused private equity, medical equipment finance companies, and government-backed loan programs that few operators know how to navigate simultaneously. Healthcare capital raising in 2026 requires operators to understand which instrument fits their specific situation — and to approach the market with the documentation that capital providers in this space actually need.


Why Healthcare Capital Is Different

Healthcare businesses have characteristics that make them simultaneously attractive and challenging for capital providers. On the attractive side: revenue is recurring, often government-backed (Medicare, Medicaid, provincial health plans), and largely inelastic to economic cycles. Demographics drive long-term demand.

On the challenging side: healthcare revenue is subject to reimbursement risk — rate changes, coding reviews, and payor mix shifts can materially alter a facility's financial profile in ways that are difficult to model from outside the clinical operations. Regulatory requirements for facility licensure, Certificate of Need (CON) filings, and accreditation add timeline risk to development and expansion projects. The practical implication is that healthcare operators who understand their reimbursement structure, can document their payor mix, and present management depth will access capital at materially better terms.


The Capital Instruments That Work for Healthcare Operators

Equipment Finance

Medical equipment finance is the most accessible instrument for healthcare operators. Equipment lenders advance 80–100% of the cost of approved medical equipment (imaging systems, surgical equipment, diagnostic devices, dental chairs, infusion systems) on 5–7 year terms, with the equipment itself serving as collateral. For a single-site operator adding a new imaging modality, equipment finance is fast (30–60 day closing), non-dilutive, and priced competitively — typically 6–10% all-in. For larger equipment programs ($5M–$30M), sale-leaseback structures on existing equipment can unlock significant liquidity from paid-off assets.

SBA and Government-Backed Loan Programs

The SBA 7(a) and 504 loan programs are underutilized by healthcare operators who assume they won't qualify. For independent medical practices, outpatient clinics, and specialty healthcare operators, SBA 7(a) loans provide up to $5M in working capital or acquisition financing at rates typically 50–150 basis points below conventional alternatives. The 504 program provides up to $5.5M for the acquisition or improvement of fixed healthcare real estate.

Healthcare-Specific A/R Revolvers

For multi-site operators, revolving credit facilities structured around healthcare accounts receivable are the working capital instrument of choice. Healthcare A/R revolvers are sized against eligible receivables from government and commercial payors — typically 70–85% advance rates on Medicare and Medicaid receivables, 60–75% on commercial insurance. As receivables are collected and new services are billed, the borrowing base resets.

Private Equity and Growth Equity for Clinical Platforms

Healthcare-focused private equity has been among the most active capital deployers in the US economy over the past decade. DSOs, multi-site ophthalmology, dermatology, orthopedics, behavioral health, and home health platforms have attracted billions in capital. The typical entry point is $3M–$10M+ in EBITDA, with platform valuations ranging from 6–12x EBITDA depending on specialty, payor mix, and growth trajectory. Family offices are increasingly active in the $1M–$5M EBITDA range for specialties with strong cash-pay components.


What Healthcare Capital Providers Underwrite

Payor Mix and Reimbursement Stability. The composition of a healthcare operator's revenue by payor — Medicare, Medicaid, commercial insurance, cash-pay — is the most important financial variable for underwriters. Sophisticated capital providers model each payor segment separately, including reimbursement rates, denial rates, and collection cycles.

Certificate of Need and Regulatory Position. For healthcare facility developers, the CON process and state licensure requirements are the primary development risk. Projects in CON states require regulatory approval before a facility can expand capacity, and CON processes can take 12–24 months with no guaranteed outcome. Capital providers will not commit to development financing without a clear path through the regulatory process.

Management Depth and Clinical Quality. Single-point-of-failure management is a risk that capital providers price explicitly. For clinical platform acquisitions, lenders and equity investors want to see management depth below the founding physician level — administrative leadership, revenue cycle management, and clinical quality infrastructure that would remain intact if the founding physician reduced their clinical hours.


Structuring Your Healthcare Capital Raise

Equipment finance is frequently the right starting point for single-site and early-stage operators — it is fast, non-dilutive, and builds a credit relationship with a healthcare-focused lender that can support subsequent facility-level financing. For operators approaching a growth equity raise, the preparation work mirrors any institutional capital process: clean financials, documented payor mix, CPARS-equivalent quality metrics, and a management team that extends below the founding physician.

"Healthcare investors are underwriting the revenue cycle as much as the clinical model. Operators who can demonstrate clean billing practices, low denial rates, and consistent collection timelines access capital on substantially better terms."

Engage an advisor who understands healthcare reimbursement, CON dynamics, and the specific payor mix characteristics of your specialty before approaching the capital market. The documentation requirements in healthcare capital raises are more specific than in most other sectors, and coming to the first investor meeting with the right package compresses the timeline to close significantly.


Connect With OAKRG

OAKRG advises healthcare operators, medical facility developers, and clinical platform builders on capital raises spanning equipment finance, healthcare credit facilities, government-backed lending, and growth equity introductions.

Connect With Our Team ↓ Download Overview